PubMed

NIH conference. Antiretroviral therapy in AIDS.

Broder S, Mitsuya H, Yarchoan R, Pavlakis GN.

Ann Intern Med. 1990 Oct 15;113(8):604-18. Review.PMID: 1698042 [PubMed - indexed for MEDLINE]Related articles

Targeted therapy of human immunodeficiency virus-related disease.

Mitsuya H, Yarchoan R, Kageyama S, Broder S.

FASEB J. 1991 Jul;5(10):2369-81. Review.PMID: 1712326 [PubMed - indexed for MEDLINE]Related articlesFree article

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.

Yarchoan R, Broder S.

N Engl J Med. 1987 Feb 26;316(9):557-64. Review.PMID: 3543683 [PubMed - indexed for MEDLINE]Related articles

Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

Kamali F.

Clin Investig. 1993 May;71(5):392-405. Review.PMID: 7685214 [PubMed - indexed for MEDLINE]Related articles

In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors.

Hayashi S, Fine RL, Chou TC, Currens MJ, Broder S, Mitsuya H.

Antimicrob Agents Chemother. 1990 Jan;34(1):82-8.PMID: 1691616 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular targets for AIDS therapy.

Mitsuya H, Yarchoan R, Broder S.

Science. 1990 Sep 28;249(4976):1533-44. Review.PMID: 1699273 [PubMed - indexed for MEDLINE]Related articles

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.

Perno CF, Yarchoan R, Cooney DA, Hartman NR, Gartner S, Popovic M, Hao Z, Gerrard TL, Wilson YA, Johns DG, et al.

J Exp Med. 1988 Sep 1;168(3):1111-25.PMID: 2844951 [PubMed - indexed for MEDLINE]Related articlesFree article

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.PMID: 12662125 [PubMed - indexed for MEDLINE]Related articles

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Daluge SM, Good SS, Faletto MB, Miller WH, St Clair MH, Boone LR, Tisdale M, Parry NR, Reardon JE, Dornsife RE, Averett DR, Krenitsky TA.

Antimicrob Agents Chemother. 1997 May;41(5):1082-93.PMID: 9145874 [PubMed - indexed for MEDLINE]Related articlesFree article

Initial clinical experience with dideoxynucleosides as single agents and in combination therapy.

Yarchoan R, Pluda JM, Perno CF, Mitsuya H, Thomas RV, Wyvill KM, Broder S.

Ann N Y Acad Sci. 1990;616:328-43. Review.PMID: 2078027 [PubMed - indexed for MEDLINE]Related articles

Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.

Yang SS, Fliakas-Boltz V, Bader JP, Buckheit RW Jr.

Leukemia. 1995 Oct;9 Suppl 1:S75-85.PMID: 7475321 [PubMed - indexed for MEDLINE]Related articles

Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides.

Pizzo PA.

Am J Med. 1990 May 21;88(5B):16S-19S. Review.PMID: 2159704 [PubMed - indexed for MEDLINE]Related articles

Perspectives for the chemotherapy of AIDS.

De Clercq E.

Anticancer Res. 1987 Sep-Oct;7(5B):1023-38. Review.PMID: 3324934 [PubMed - indexed for MEDLINE]Related articles

Chemotherapeutic approaches to human immunodeficiency virus infections.

Baba M.

Fukushima J Med Sci. 1992 Jun;38(1):1-18. Review.PMID: 1284048 [PubMed - indexed for MEDLINE]Related articles

[New therapeutic trends in AIDS]

Perno CF, Caliò R.

Clin Ter. 1992 Feb;140(2):197-204. Review. Italian. PMID: 1314726 [PubMed - indexed for MEDLINE]Related articles

Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.

Kong XB, Zhu QY, Ruprecht RM, Watanabe KA, Zeidler JM, Gold JW, Polsky B, Armstrong D, Chou TC.

Antimicrob Agents Chemother. 1991 Oct;35(10):2003-11.PMID: 1722077 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

Henry K, Erice A, Tierney C, Balfour HH Jr, Fischl MA, Kmack A, Liou SH, Kenton A, Hirsch MS, Phair J, Martinez A, Kahn JO.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):339-49.PMID: 9833742 [PubMed - indexed for MEDLINE]Related articles

Current use of anti-HIV drugs in AIDS.

Clumeck N.

J Antimicrob Chemother. 1993 Jul;32 Suppl A:133-8. Review.PMID: 8407695 [PubMed - indexed for MEDLINE]Related articles

Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.

Perno CF, Yarchoan R, Cooney DA, Hartman NR, Webb DS, Hao Z, Mitsuya H, Johns DG, Broder S.

J Exp Med. 1989 Mar 1;169(3):933-51.PMID: 2538549 [PubMed - indexed for MEDLINE]Related articlesFree article